Tag Archives: Dengue vaccine

30Apr/21

Dengue Vaccine! Tetravalent Vaccine TAK-003 Enters Review in EU

April 30, 2021Vaccine NewsDengue vaccinebiovaccine

Takeda Pharmaceutical recently announced that the European Drug Administration (EMA) has accepted the declaration of its dengue vaccine TAK-003, which is developed for people between the ages of 4 and 60 toRead More…

12Nov/18

Sanofi Dengvaxia Awarded US FDA Priority Review as the World’s First Dengue Vaccine

November 12, 2018Vaccine NewsDengue vaccine, live attenuated vaccine, viral vaccinebiovaccine

Sanofi, a French pharmaceutical giant, recently announced that the US Food and Drug Administration (FDA) has accepted the dengue vaccine Dengvaxia’s Biologics License Application (BLA) and granted priority review. The vaccine isRead More…